0:00
15:43
Systemic amyloidosis from transthyretin (ATTR) protein is increasingly recognized as an important cause of heart failure in older people. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses the diagnosis and treatment of ATTR protein cardiomyopathy with Frederick L. Ruberg, MD, of the Boston University Chobanian & Avedisian School of Medicine.
Related Content:
Altri episodi di "JAMA Clinical Reviews"
Non perdere nemmeno un episodio di “JAMA Clinical Reviews”. Iscriviti all'app gratuita GetPodcast.